The human genome project: Benefits and risks to society

被引:0
|
作者
Wattanapitayakul, S
Schommer, JC
机构
[1] Ohio State Univ, Coll Pharm, Div Pharmacol, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Pharm, Dept Pharmaceut Care & Hlth Syst, Columbus, OH 43210 USA
来源
DRUG INFORMATION JOURNAL | 1999年 / 33卷 / 03期
关键词
human genome project; public policy;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The human genome project was initiated in 1990 to study the structure and characteristics of human DNA that are important for understanding gene functions and their relation to diseases. The large-scale genome research has driven the technology advancement in genetic testing drug design, gene therapy, and other genetic related areas such as pharmacogenetics. Although the project reveals potential benefits, it raises ethical, legal, and social issues. The outcomes of individuals' genetic information disclosure may lead to conJcidentiality and genetic discrimination issues. In addition, clinical relevance of genetic testing and psychological effect from the results are debatable. This article discusses the potential benefits and risks from the human genome project.
引用
收藏
页码:729 / 735
页数:7
相关论文
共 50 条